187 related articles for article (PubMed ID: 21750294)
1. Clinically relevant changes in family history of cancer over time.
Ziogas A; Horick NK; Kinney AY; Lowery JT; Domchek SM; Isaacs C; Griffin CA; Moorman PG; Edwards KL; Hill DA; Berg JS; Tomlinson GE; Anton-Culver H; Strong LC; Kasten CH; Finkelstein DM; Plon SE
JAMA; 2011 Jul; 306(2):172-8. PubMed ID: 21750294
[TBL] [Abstract][Full Text] [Related]
2. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
Sirovich BE; Schwartz LM; Woloshin S
JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants.
Abdel-Rahman O
Clin Breast Cancer; 2020 Aug; 20(4):300-306. PubMed ID: 32327298
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network.
Lowery JT; Horick N; Kinney AY; Finkelstein DM; Garrett K; Haile RW; Lindor NM; Newcomb PA; Sandler RS; Burke C; Hill DA; Ahnen DJ
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):601-10. PubMed ID: 24501379
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.
Mai PL; Wideroff L; Greene MH; Graubard BI
Public Health Genomics; 2010; 13(7-8):495-503. PubMed ID: 20389042
[TBL] [Abstract][Full Text] [Related]
6. Breast, colorectal, and skin cancer screening practices and family history of cancer in U.S. women.
Shah M; Zhu K; Palmer RC; Jatoi I; Shriver C; Wu H
J Womens Health (Larchmt); 2007 May; 16(4):526-34. PubMed ID: 17521256
[TBL] [Abstract][Full Text] [Related]
7. Calculating the Starting Age for Screening in Relatives of Patients With Colorectal Cancer Based on Data From Large Nationwide Data Sets.
Tian Y; Kharazmi E; Brenner H; Xu X; Sundquist K; Sundquist J; Fallah M
Gastroenterology; 2020 Jul; 159(1):159-168.e3. PubMed ID: 32251666
[TBL] [Abstract][Full Text] [Related]
8. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
9. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
10. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
11. Endoscopist Specialty Predicts the Likelihood of Recommending Cessation of Colorectal Cancer Screening in Older Adults.
Calderwood AH; Anderson JC; Robinson CM; Butterly LF
Am J Gastroenterol; 2018 Dec; 113(12):1862-1871. PubMed ID: 30390031
[TBL] [Abstract][Full Text] [Related]
12. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.
Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Nomura AM; Kolonel LN
Am J Epidemiol; 2004 Apr; 159(8):750-8. PubMed ID: 15051584
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
14. Revised Australian national guidelines for colorectal cancer screening: family history.
Jenkins MA; Ait Ouakrim D; Boussioutas A; Hopper JL; Ee HC; Emery JD; Macrae FA; Chetcuti A; Wuellner L; St John DJB
Med J Aust; 2018 Nov; 209(10):455-460. PubMed ID: 30359558
[TBL] [Abstract][Full Text] [Related]
15. The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.
Carere DA; VanderWeele T; Moreno TA; Mountain JL; Roberts JS; Kraft P; Green RC;
BMC Med Genomics; 2015 Oct; 8():63. PubMed ID: 26468061
[TBL] [Abstract][Full Text] [Related]
16. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
[TBL] [Abstract][Full Text] [Related]
17. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative.
Beebe-Dimmer JL; Yee C; Paskett E; Schwartz AG; Lane D; Palmer NRA; Bock CH; Nassir R; Simon MS
BMC Cancer; 2017 Dec; 17(1):848. PubMed ID: 29237415
[TBL] [Abstract][Full Text] [Related]
18. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.
Chen YC; Page JH; Chen R; Giovannucci E
Prostate; 2008 Oct; 68(14):1582-91. PubMed ID: 18646000
[TBL] [Abstract][Full Text] [Related]
19. Colonoscopic surveillance for family history of colorectal cancer: are NHMRC guidelines being followed?
Yusoff IF; Hoffman NE; Ee HC
Med J Aust; 2002 Feb; 176(4):151-4. PubMed ID: 11913913
[TBL] [Abstract][Full Text] [Related]
20. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
